Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain. The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with six Republicans joining every Democrat on the panel. Notably,...
Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain. The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with six Republicans joining every Democrat on the panel. Notably,...
<iframe src="https://statesidedaily.com/embed/cluster/18772caa16bccc6059bdedb06853ca8f3de02974" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Senate panel advances legislation capping private insurance insulin at $35"></iframe>
